Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-09-001230
Filing Date
2009-07-22
Accepted
2009-07-22 15:05:03
Documents
1
Group Members
BAM CAPITAL, LLCBAM MANAGEMENT, LLCHAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 oxigene_sch13g.htm SC 13G 177981
  Complete submission text file 0000929638-09-001230.txt   180002
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Subject) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45691 | Film No.: 09957022
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G